Tokai Pharmaceuticals Appoints Adrian M. Senderowicz, M.D., as Chief Medical Officer and Vice President, Medical Development
06:30 EDT 9 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on
developing new treatments for prostate cancer, today announced the
appointment of Adrian M. Senderowicz, M.D., to the position of chief
medical officer and vice...
Other Sources for this Article
Pure Communications Inc.
Sheryl Seapy, 949-608-0841
More From BioPortfolio on "Tokai Pharmaceuticals Appoints Adrian M. Senderowicz, M.D., as Chief Medical Officer and Vice President, Medical Development"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
